Outcomes within 90 d after interruption of anticoagulation according to treatment group
| Warfarin, n (%) (95% CI) | DOACs, n (%) (95% CI) | HR (95% CI) for DOACs versus warfarin | |
| All events | 43 (27.4) (20.6 to 35.1) | 36 (25.0) (18.2 to 32.9) | 0.98 (0.63 to 1.52) |
| All thromboembolic complications | 8 (5.0) (2.2 to 9.8) | 10 (6.9) (3.4 to 12.4) | 1.40 (0.55 to 3.52) |
| Death (all cause) | 35 (22.3) (16.0 to 29.6) | 26 (18.1) (12.12 to 25.3) | 0.88 (0.53 to 1.45) |
| Stroke | 3 (1.9) | 3 (2.1) | |
| TIA | 1 (0.6) | 3 (2.1) | |
| Systemic thromboembolism | 1 (0.6) | 1 (0.7) | |
| MI | 3 (1.9) | 3 (2.1) |
DOACs, direct oral anticoagulants; MI, myocardial infraction; TIA, transient ischemic attack.